Designation granted by FDA recognizes the potential of plixorafenib, a novel, investigational paradox breaker and BRAF inhibitor, to provide substantial improvement over available therapies First ...

The FDA has delayed its target decision date for Orca Bio’s blood cancer cell therapy candidate Orca-T by three months to July 6. The review extension comes after the company submitted additional data ...

Nanofilm electrodes capable of detecting stress in plants through bioelectric potentials could pave the way for more resilient agriculture, report researchers from Institute of Science Tokyo. Thanks ...

In 2021, dermatologist David Ozog was on holiday with his family in the Bahamas, when his 18-year-old son had a massive stroke. The teenager was airlifted to Florida, and then to Chicago for surgery.

LOS ANGELES, March 24, 2026 /PRNewswire/ -- Electrome Corp, a bioelectric therapeutics company, today announced the launch of its strategic partnership with BioElectronics Corp (BIEL), the pioneer in ...

Sartorius’ life science group is launching an integrated system for the production and quality control (QC) of autologous cell therapies. The modular Eveo Cell Therapy Platform is designed to address ...

Boston Scientific Corp.’s Rezūm Water Vapor Therapy is superior at providing symptom relief for men with benign prostatic hyperplasia (BPH) than combination drug therapy, according to 12-month data ...

ImmunityBio (IBRX) shares gained on Friday after the cancer drug developer announced the successful conclusion of two manufacturing engineering programs designed to validate its Cytokine-Enriched NK ...

Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically engineering a chimeric antigen receptor on the surface of the patient's T ...

Electro Zen Acupuncture, a Portland-based clinic specializing in electroacupuncture treatments, has expanded its comprehensive treatment protocols to address the growing demand for effective ...